Literature DB >> 19433434

The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis.

Deanne Malenfant1, Michelle Catton, Janet E Pope.   

Abstract

OBJECTIVE: Conventional treatment for RP is limited due to side effects, and complementary and alternative medicines (CAM) are widely used by the population. Our objective was to find an effective and well-tolerated CAM for the treatment of RP.
METHODS: Using MEDLINE, EMBASE and AMED, 20 randomized controlled trials (RCTs) were found and divided into nine treatment subcategories: acupuncture (n = 2 trials), anti-oxidants (n = 2), biofeedback (n = 5), essential fatty acids (n = 3), Ginkgo biloba (n = 1), L-arginine (n = 2), laser (n = 3), glucosaminoglycans (n = 1) and therapeutic gloves (n = 1). Trials in each subcategory were meta-analysed together.
RESULTS: Several categories did not have enough trials to do a meta-analysis and most trials were negative, of poor quality and done prior to 1990. Biofeedback was negative for a change in frequency, duration and severity of RP attacks, and actually favoured control (sham biofeedback; P < 0.02). The therapeutic glove favoured active treatment (P < 0.00001). Laser resulted in one less RP attack on average over 2 weeks vs sham [weighted mean difference (WMD) 1.18; 95% CI 1.06, 1.29], and a change in severity of attacks (WMD 1.98; 95% CI 1.57, 2.39; P < 0.05). No significant differences were found in the nutritional supplements that were studied.
CONCLUSIONS: There is a need for well-designed trials of CAM in RP. The literature is inconclusive except that biofeedback does not work for RP, therapeutic gloves may improve RP (but results may not be generalizable due to single trial site and no intent-to-treat analysis) and laser may be effective but the improvement may not be clinically relevant.

Entities:  

Mesh:

Year:  2009        PMID: 19433434     DOI: 10.1093/rheumatology/kep039

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Connective tissue diseases: New evidence-based guidelines for treating SSc.

Authors:  Janet E Pope
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

Review 2.  [Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].

Authors:  M Frerix; F M P Meier; W Hermann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

3.  Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial.

Authors:  Birte Sporbeck; Kirsten Mathiske-Schmidt; Silke Jahr; Dörte Huscher; Mike Becker; Gabriela Riemekasten; Ines Taufmann; Gerd-Rüdiger Burmester; Stephanie Pögel; Anett Reisshauer
Journal:  Rheumatol Int       Date:  2011-04-08       Impact factor: 2.631

4.  A Randomized Controlled Trial of Acupressure for the Treatment of Raynaud's Phenomenon: The difficulty of conducting a trial in Raynaud's phenomenon.

Authors:  Heather Gladue; Veronica Berrocal; Richard Harris; Pei-Suen Tsou; Gautam Edhayan; Ray Ohara; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-05-02

Review 5.  Complementary therapies for patients with systemic sclerosis.

Authors:  Kimberly Showalter; Aileen Hoffmann; Nicole DeCredico; Anjali Thakrar; Esperanza Arroyo; Isaac Goldberg; Monique Hinchcliff
Journal:  J Scleroderma Relat Disord       Date:  2019-03-29

6.  Application of dynamic indocyanine green perfusion imaging for evaluation of vasoactive effect of acupuncture: a preliminary follow-up study on normal healthy volunteers.

Authors:  Yuri An; Jong Wook Jeon; Kihwan Kwon; Chulhee Choi
Journal:  Med Devices (Auckl)       Date:  2014-02-20

Review 7.  Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.

Authors:  Manal M Fardoun; Joseph Nassif; Khodr Issa; Elias Baydoun; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-11-16       Impact factor: 5.810

8.  The influence of Multiwave Locked System (MLS) laser therapy on clinical features, microcirculatory abnormalities and selected modulators of angiogenesis in patients with Raynaud's phenomenon.

Authors:  Anna Kuryliszyn-Moskal; Jacek Kita; Agnieszka Dakowicz; Sylwia Chwieśko-Minarowska; Diana Moskal; Bożena Kosztyła-Hojna; Ewa Jabłońska; Piotr Adrian Klimiuk
Journal:  Clin Rheumatol       Date:  2014-05-13       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.